Drug Profile


Alternative Names: DNG/E2; E2/DNG; Ethinylestradiol/dienogest; Jeanine; MP 2000/Mikropille; Valette; Valette Plus

Latest Information Update: 07 Mar 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Jenapharm
  • Class Alkylated estrogenic steroids; Antiandrogens; Estrenes; Hormonal contraceptives; Norpregnatrienes; Oral contraceptives; Testosterone congeners
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Pregnancy

Most Recent Events

  • 07 Mar 2017 Chemical structure information added
  • 09 Feb 2015 Launched for Contraception/Pregnancy (Prevention) in Austria, Portugal, Czech Republic, Poland, Australia, Ukraine and Russia (PO) prior to February 2015
  • 01 Mar 2011 Bayer Schering Pharma is now called Bayer Healthcare Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top